Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials.
Eur J Clin Pharmacol
; 75(5): 603-607, 2019 May.
Article
en En
| MEDLINE
| ID: mdl-30613860
ABSTRACT
PURPOSE:
To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness).METHODS:
Systematic review by 2 independent reviewers. Consultation of the Medline, Cochrane and ClinicalTrials.gov databases until September 2018. Keywords used Acetylleucine, Tanganil®, Acetyl-DL-leucine, Acetyl-leucine. Trial selection randomised controlled trials (RCTs) comparing acetylleucine against placebo.RESULTS:
Up until 2018, no RCTs have been published on the efficacy of acetylleucine in vertigo/dizziness.CONCLUSION:
There is no solid evidence of the efficacy of acetylleucine in vertigo/dizziness. Given its frequent prescription and the cost generated for the French social security system, high-quality randomised trials should be carried out to assess its efficacy.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Vértigo
/
Mareo
/
Leucina
Tipo de estudio:
Clinical_trials
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Revista:
Eur J Clin Pharmacol
Año:
2019
Tipo del documento:
Article
País de afiliación:
Francia